Skip to Content Facebook Feature Image

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

Business

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
Business

Business

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

2026-01-20 19:00 Last Updated At:19:15

Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and more

LOS ANGELES and MELBOURNE, Australia, Jan. 20, 2026 /PRNewswire/ -- 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading "CT:VQ™" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging.

CT:VQ™ is 4DMedical's FDA-cleared, SaaS technology that provides ventilation and perfusion insights from CT imaging. Within just four months of FDA clearance, CT:VQ was deployed by four elite U.S. academic medical centers: Stanford, Cleveland Clinic, University of Miami, and UC San Diego Health. These rapid adoptions reflect growing interest from clinicians seeking quantified, actionable and functional information not available from traditional imaging--but increasingly vital to support diagnosis, treatment planning, and longitudinal monitoring.

"This is an extraordinarily important and validating event for multiple reasons," says Andreas Fouras, PhD, 4DMedical Founder and CEO. "First, it reflects growing global recognition of the technological leadership of 4DMedical, including our groundbreaking products such as CT:VQ™. And it recognizes both the commercial progress and even greater growth potential we have in the U.S. With this strong institutional backing and a strengthened balance sheet, we will scale adoption, accelerate R&D, deepen partnerships, and dominate the global marketplace for software-based lung imaging tools."

What the funding enables for hospitals and health systems

4DMedical will use the funding to expand U.S. availability of CT:VQ™ and support health systems with implementation at scale, including:

  • Commercial expansion across U.S. academic medical centers and health systems, with a focus on real-world adoption and multidisciplinary use
  • Customer success, training, and technical support to help integrate CT:VQ™ into existing clinical workflows and drive consistent utilization
  • Ongoing research and development to expand 4DMedical's technology leadership, product portfolio and capabilities in functional lung imaging
  • Operational scale and flexibility to support additional growth opportunities and sustained clinical partnerships

Following the raise, 4DMedical reported a pro forma cash position exceeding US$130+ million (AU$200+ million), which will support the company's U.S. expansion strategy and growing installed base.

Built to integrate into clinical workflows

4DMedical's products are delivered through a Software-as-a-Service (SaaS) model designed to integrate with existing hospital infrastructure. The company also highlighted strategic partnerships, including with Philips, aimed at supporting broader adoption pathways.

Availability

Hospitals and imaging networks interested in evaluating CT:VQ™ can contact 4DMedical for implementation information, workflow considerations, and a demonstration.

About 4DMedical

4DMedical Limited (ASX:4DX) is a global medical technology company that creates and deploys the most advanced software-based cardiothoracic imaging technology—integrating both proprietary algorithms and artificial intelligence. 4DMedical's software platform delivers deep, quantitative, insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease with significantly greater precision.

These insights help pulmonologists, radiologists and hospital teams quantify regional lung function, support diagnosis and disease monitoring, and inform treatment and surgical planning. 4DMedical's solutions are designed to integrate into existing clinical workflows. They provide actionable, patient-specific information that supports better decision-making and operational efficiency across a range of respiratory conditions. Learn more at www.4dmedical.com.

Photo - https://mma.prnasia.com/media2/2865006/4DMedical_Respiratory_Imaging.jpg?p=medium600

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

SINGAPORE, Jan. 21, 2026 /PRNewswire/ -- The partnership between NLCS (Singapore) and the Wheelchair Rugby Association Singapore began through the initiative of an NLCS (Singapore) student who, after becoming involved with the association, learned that WRAS was at risk of losing access to its long-standing training venue. Recognising the significance of the programme and the impact it has on its athletes, the student brought a detailed proposal to senior staff, advocating for meaningful, long-term support.

That proposal led to a formal partnership in which NLCS (Singapore) committed both sustained sponsorship and access to its sporting facilities, enabling WRAS athletes to practise, and host matches in a stable and supportive environment. The partnership reflects the school's belief in student leadership and in education that extends beyond the classroom.

WRAS has since continued to grow as a competitive and inclusive sporting community, providing athletes with opportunities to train at a high level while fostering resilience, teamwork, and a strong sense of belonging.

"Wheelchair rugby fosters community inclusion and belonging by providing a structured, supportive environment where individuals with disabilities can participate in a demanding team sport," said Clare, Secretary and Volunteer at the Wheelchair Rugby Association Singapore.

The strength of this partnership was evident at a recent ceremony, where WRAS athletes were presented with their national jerseys ahead of their participation in the ASEAN Para Games. The event was a moving occasion, celebrating not only sporting excellence but also the collective effort behind the athletes' journey.

Paul Friend, Director of NLCS (Singapore), attended the ceremony and reflected on the relationship between the school and WRAS:

"This partnership began because one of our students saw something important at risk and was determined to act. What followed was a thoughtful, well-argued case for how we could help in a way that really mattered. Supporting WRAS has been immensely rewarding, not just because of what it enables for the athletes, but because of what our own students learn through being connected with such inspiring people. It is a relationship from which we have all benefited."

NLCS (Singapore) looks forward to continuing its partnership with WRAS and to supporting the athletes as they compete on the regional stage, while remaining committed to student-led initiatives that create meaningful impact beyond the school community.

About North London Collegiate School (Singapore)  

Founded in August 2020, North London Collegiate School (Singapore) is a British International School offering the academically ambitious NLCS curriculum, followed by the International Baccalaureate (IB) Middle Years Programme and culminating in the IB Diploma Programme. 

Drawing on 175 years of educational heritage from its founding school in the UK, NLCS (Singapore) nurtures individuals to be intellectually curious, socially confident, and grounded in compassion through a rigorous academic framework, rich co-curricular opportunities, and exceptional pastoral care.

Situated on Depot Road, the School is part of a global family of schools committed to educational excellence and developing global citizens.

To learn more about NLCS (Singapore), please visit our website (https://nlcssingapore.sg/) and follow us on Instagram, Facebook, YouTube, and LinkedIn.

For media enquiries, please contact the NLCS (Singapore) Marketing Team
Email: marketing@nlcssingapore.sg

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

North London Collegiate School (Singapore) celebrates the Wheelchair Rugby Association Singapore (WRAS) athletes participating in the upcoming ASEAN Para Games

North London Collegiate School (Singapore) celebrates the Wheelchair Rugby Association Singapore (WRAS) athletes participating in the upcoming ASEAN Para Games

Recommended Articles